We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 (IFM2008)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01206205
First Posted: September 21, 2010
Last Update Posted: May 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Celgene Corporation
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
University Hospital, Toulouse